Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2026-01-22 00:00:00 ET · period of report 2026-01-20 · accession 0001628280-26-003139 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-22 | 2026-01-20 | BMRN | Ramchandani Rashmi Virendra | VP, CAO | A - Grant | $0.00 | +25.6K | 25.6K | New | $0 |
| D | 2026-01-22 | 2026-01-20 | BMRN | Ramchandani Rashmi Virendra | VP, CAO | A - Grant | $0.00 | +18.2K | 18.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-20 | A | A | 18,540 | $0.00 | 18,540 | D | — | — | (F1) Restricted stock units granted on January 20, 2026. Price not applicable. |
| 2 | Common | Common Stock | 2026-01-20 | A | A | 7,070 | $0.00 | 25,610 | D | — | — | (F1) Restricted stock units granted on January 20, 2026. Price not applicable. |
| 3 | Derivative | Stock Option (Right to Buy Common Stock) | 2026-01-20 | A | A | 18,220 | $0.00 | 18,220 | D | $56.31 · 2027-01-20 to 2036-01-19 | 18,220 Common Stock | (F2) Option grant vests 12/48th on January 20, 2027 and 1/48th on the 20th day of each month thereafter. |